Southwest Chemical Dependency Program is a licensed substance use treatment provider in Dillon, MT, listed in the SAMHSA treatment directory. An intensive outpatient program lets clients attend structured treatment several days a week while living at home. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Substance use treatmentTreatment for co-occurring disorders plus serious mental illness (SMI) in adults
Medications
Buprenorphine used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsMedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than MedicaidSAMHSA funding/block grants
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState department of health
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare
Hospital inpatient/24-hour hospital inpatientResidential/24-hour residentialHospital inpatient detoxificationFederal, or any government funding for substance use treatment programsMedicare
OutpatientResidential/24-hour residentialOutpatient day treatment or partial hospitalizationIHS/Tribal/Urban (ITU) fundsFederal military insurance (e.g., TRICARE)